TY  - JOUR
TI  - The Prevalence of Sarcopenia in Patients  with Schizophrenia
AB  - Objective: In this study, we aimed to investigate the frequency of sarcopenia in patients with  schizophrenia and the risk factors that may be associated with sarcopenia. Methods: We recruited 72 schizophrenia patients who had registered in the schizophrenia specialized  unit of Çukurova University. The socio-demographic variable form was filled. Each patient underwent  physical mass, strength, and performance tests to confirm the diagnosis of sarcopenia (SP), which was  made according to the criteria of European Consensus. Results: Mean age of the patients was 39.50 (19-65) years for the possible sarcopenia group and 37.00  (21-65) years for without SP group. Possible sarcopenia was 36.1% (n=26), and SP and severe SP were  0.0% in schizophrenia patients. Total body water (TBW) (37.60 vs. 43.90) and bone mineral density  (2.70 vs. 3.10) values were significantly lower in the possible SP group compared to the non-sarcopenia  group (P=.011 and P=.025, respectively). However, it was found that muscle mass (kg) (51.05 vs.  58.65) and muscle strength (kg/kg) (20.70 vs. 33.15) were significantly lower in the possible SP group  compared to the non-sarcopenia group (P=.042 and P=.001, respectively). Compared to the non sarcopenia group, patient exercising was less in the possible SP group (4 vs. 9, P=.001), while walking  speeds (m/s) were statistically faster in the possible SP group (6.74 vs. 5.98, P=.010). Conclusion: This is the first study that investigated SP in schizophrenia patients. Sarcopenia was found  more frequently in schizophrenia patients than in the general population
AU  - Tamam, Lut
AU  - çakmak, soner
AU  - namlı, zeynep
AU  - Erşahinoğlu, Emre
AU  - Demirkol, Mehmet Emin
AU  - Bülbül, Feridun
DO  - 10.5152/pcp.2021.20175
PY  - 2021
JO  - Psychiatry and clinical psychopharmacology (Online)
VL  - 31
IS  - 1
SN  - 2475-0581
SP  - 60
EP  - 66
DB  - TRDizin
UR  - http://search/yayin/detay/1169234
ER  -